In The News

Press Releases

In The News

Industry Events

Catalogue

Videos

In The News

24 Apr,2025

In - Depth Analysis of Key Points of Catheter Technology in Vascular Interventional Procedures

25 Mar,2025

In 2025, the National medical device sampling inspection work promotion meeting was held

On March 24, the National medical device sampling inspection work promotion meeting was held in Chengdu. The meeting summarized the effectiveness of the 2024 sampling work, in-depth analysis of the current situation, and research and deployment of the key work of 2025 sampling.

01 Apr,2025

Ask an electrophysiologist: What roles do PFA and RFA play in the treatment of AFib?

Both are types of cardiac ablation, but are distinct in a few key ways. An expert weighs in on when and how they can be harnessed. It’s been called “the 21st century cardiovascular disease epidemic,” affecting millions every year and raising the odds of serious health risks. Atrial fibrillation (AFib), the most common type of heart rhythm disorder,1 is a major cause of stroke, heart failure, heart attack, dementia and death.2 About 1 in 3 to 5 people over the age of 45 will develop the condition,3 and it’s only becoming more prevalent: Between 2010 and 2019, cases rose from 33.5 million to 59 million globally—and these figures likely underestimate the impact, as many people don’t know they have AFib until they experience symptoms or a stroke. 4 What’s more, the number of people affected by AFib could increase by more than 60% by 2050, highlighting the critical need for effective treatment options.5

03 Oct,2024

How self-administered medicines are transforming chronic disease care

With nearly 880 million adults estimated to be living with obesity worldwide, injectable weight loss drugs have become one of the biggest stories in medicine. Commonly referred to as GLP-1s, these drugs have the ability to manage diabetes and the effects of obesity. Additionally, recent clinical data suggests these drugs help reduce the risk of cardiovascular disease, stroke and kidney failure. Their adoption has grown at an unprecedented scale, signaling a shift in how patients navigate chronic weight management, with growing acceptance and demand for self-administered treatment taken at home.

25 Apr,2024

For real progress in corporate responsibility, choose action in line with company values

Human health is intertwined with the health of our communities and of our planet. That’s one reason health care innovation companies like Boston Scientific make meeting our environmental, social and governance responsibilities a priority.

< 1 >

Industry Events

Show all >

Contact Us

Submit
%{tishi_zhanwei}%

Videos

Watch the video，Learn more about our products and services.Diagsensor is dedicated to the research and development of ultra-micro sensors for vital signs monitoring

Learn More

Social Media

Our Social Media Channels Keep You Informed.

facebook linkedin
No data

No data

Sales@diagsensor.com

Copyright © Diagsensor

Business License

SEO Label

Powered by：CEglobal